File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Conference Paper: Addition of cetuximab to oxaliplatin-based chemotherapy on liver and spleen size and thrombocytopenia in patients with metastatic colorectal cancer
  • Basic View
  • Metadata View
  • XML View
TitleAddition of cetuximab to oxaliplatin-based chemotherapy on liver and spleen size and thrombocytopenia in patients with metastatic colorectal cancer
 
AuthorsLee, V
Fang, WJ
Lam, KO
Choi, CW
Ng, S
Ho, G
Cheng, T
Liu, RKY
Leung, TW
Kwong, DLW
Zheng, SS
 
KeywordsMedical sciences
Oncology
 
Issue Date2012
 
PublisherOxford University Press. The Journal's web site is located at http://annonc.oxfordjournals.org/
 
CitationThe 14th World Congress of the European Society for Medical Oncology (ESMO) on Gastrointestinal Cancer, Barcelona, Spain, 27–30 June 2012. In Annals of Oncology, 2012, v. 23 suppl. 4, p. iv94, abstract P-0224 [How to Cite?]
DOI: http://dx.doi.org/10.1093/annonc/mds153
 
AbstractINTRODUCTION: A previous retrospective study revealed that oxaliplatin could induce splenic enlargement which in turn was associated with thrombocytopenia in patients with early stage colorectal cancer. However it has not still been known whether cetuximab aggravates or alleviates such effects in patients with metastatic colorectal cancer. We performed a retrospective study to investigate the effect of addition of cetuximab to oxaliplatin-based regimen as 1st line palliative chemotherapy on liver and spleen size and its association with thrombocytopenia in patients with metasta…
 
DescriptionPosters: P-0224
 
ISSN0923-7534
2013 Impact Factor: 6.578
 
DOIhttp://dx.doi.org/10.1093/annonc/mds153
 
DC FieldValue
dc.contributor.authorLee, V
 
dc.contributor.authorFang, WJ
 
dc.contributor.authorLam, KO
 
dc.contributor.authorChoi, CW
 
dc.contributor.authorNg, S
 
dc.contributor.authorHo, G
 
dc.contributor.authorCheng, T
 
dc.contributor.authorLiu, RKY
 
dc.contributor.authorLeung, TW
 
dc.contributor.authorKwong, DLW
 
dc.contributor.authorZheng, SS
 
dc.date.accessioned2012-09-20T08:15:21Z
 
dc.date.available2012-09-20T08:15:21Z
 
dc.date.issued2012
 
dc.description.abstractINTRODUCTION: A previous retrospective study revealed that oxaliplatin could induce splenic enlargement which in turn was associated with thrombocytopenia in patients with early stage colorectal cancer. However it has not still been known whether cetuximab aggravates or alleviates such effects in patients with metastatic colorectal cancer. We performed a retrospective study to investigate the effect of addition of cetuximab to oxaliplatin-based regimen as 1st line palliative chemotherapy on liver and spleen size and its association with thrombocytopenia in patients with metasta…
 
dc.description.naturelink_to_OA_fulltext
 
dc.descriptionPosters: P-0224
 
dc.identifier.citationThe 14th World Congress of the European Society for Medical Oncology (ESMO) on Gastrointestinal Cancer, Barcelona, Spain, 27–30 June 2012. In Annals of Oncology, 2012, v. 23 suppl. 4, p. iv94, abstract P-0224 [How to Cite?]
DOI: http://dx.doi.org/10.1093/annonc/mds153
 
dc.identifier.doihttp://dx.doi.org/10.1093/annonc/mds153
 
dc.identifier.epageiv94
 
dc.identifier.hkuros206044
 
dc.identifier.hkuros227944
 
dc.identifier.issn0923-7534
2013 Impact Factor: 6.578
 
dc.identifier.issuesuppl. 4
 
dc.identifier.spageiv94
 
dc.identifier.urihttp://hdl.handle.net/10722/165129
 
dc.identifier.volume23
 
dc.languageeng
 
dc.publisherOxford University Press. The Journal's web site is located at http://annonc.oxfordjournals.org/
 
dc.publisher.placeUnited Kingdom
 
dc.relation.ispartofAnnals of Oncology
 
dc.subjectMedical sciences
 
dc.subjectOncology
 
dc.titleAddition of cetuximab to oxaliplatin-based chemotherapy on liver and spleen size and thrombocytopenia in patients with metastatic colorectal cancer
 
dc.typeConference_Paper
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Lee, V</contributor.author>
<contributor.author>Fang, WJ</contributor.author>
<contributor.author>Lam, KO</contributor.author>
<contributor.author>Choi, CW</contributor.author>
<contributor.author>Ng, S</contributor.author>
<contributor.author>Ho, G</contributor.author>
<contributor.author>Cheng, T</contributor.author>
<contributor.author>Liu, RKY</contributor.author>
<contributor.author>Leung, TW</contributor.author>
<contributor.author>Kwong, DLW</contributor.author>
<contributor.author>Zheng, SS</contributor.author>
<date.accessioned>2012-09-20T08:15:21Z</date.accessioned>
<date.available>2012-09-20T08:15:21Z</date.available>
<date.issued>2012</date.issued>
<identifier.citation>The 14th World Congress of the European Society for Medical Oncology (ESMO) on Gastrointestinal Cancer, Barcelona, Spain, 27&#8211;30 June 2012. In Annals of Oncology, 2012, v. 23 suppl. 4, p. iv94, abstract P-0224</identifier.citation>
<identifier.issn>0923-7534</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/165129</identifier.uri>
<description>Posters: P-0224</description>
<description.abstract>INTRODUCTION: A previous retrospective study revealed that oxaliplatin could induce splenic enlargement which in turn was associated with thrombocytopenia in patients with early stage colorectal cancer. However it has not still been known whether cetuximab aggravates or alleviates such effects in patients with metastatic colorectal cancer. We performed a retrospective study to investigate the effect of addition of cetuximab to oxaliplatin-based regimen as 1st line palliative chemotherapy on liver and spleen size and its association with thrombocytopenia in patients with metasta&#8230;</description.abstract>
<language>eng</language>
<publisher>Oxford University Press. The Journal&apos;s web site is located at http://annonc.oxfordjournals.org/</publisher>
<relation.ispartof>Annals of Oncology</relation.ispartof>
<subject>Medical sciences</subject>
<subject>Oncology</subject>
<title>Addition of cetuximab to oxaliplatin-based chemotherapy on liver and spleen size and thrombocytopenia in patients with metastatic colorectal cancer</title>
<type>Conference_Paper</type>
<description.nature>link_to_OA_fulltext</description.nature>
<identifier.doi>10.1093/annonc/mds153</identifier.doi>
<identifier.hkuros>206044</identifier.hkuros>
<identifier.hkuros>227944</identifier.hkuros>
<identifier.volume>23</identifier.volume>
<identifier.issue>suppl. 4</identifier.issue>
<identifier.spage>iv94</identifier.spage>
<identifier.epage>iv94</identifier.epage>
<publisher.place>United Kingdom</publisher.place>
<bitstream.url>http://hub.hku.hk/bitstream/10722/165129/1/re01.htm</bitstream.url>
</item>